UK regulators approved a covid-19 vaccine created through Pfizer and his spouse BioNTech for emergency use, the vaccine is expected to begin to be implemented soon. Here we answer questions about the science of the vaccine, who will receive it first, to what extent you can be sure of yourself in the authorisation procedure and in the logistics of vaccination for everyone in the UK.
The RNA-containing nanoparticles are suspended in a saline solution and injected into the muscle tissue of the arm. The MSA is then absorbed through specialized immune cells, which adhere to its commands to produce the complex protein, just as they would if they were inflamed with the real virus.
The complex protein is identified as foreign through the immune formula, which attacks opposites to it. Antibodies, B cells and T cells are activated, according to Uur ‘Ahin, executive leader of the german small company BioNTech, which co-developed The Vaccine with the US pharmaceutical giant Pfizer. Immune reminiscence is also established, he says, meaning that the immune formula has learned to defeat the pathogen and is in a position to react temporarily if it encounters coronavirus again.
It has not been tested on others with severe or worsening comorities, but they will still be eligible for the vaccine. BioNTech says you have knowledge about this organization and will publish it in a few days.
The citizens of the foster homes and their caregivers take precedence, according to a formula of precedence developed through the British Joint Committee on Immunization and Immunization, followed by other persons over the age of 80 and frontline fitness workers, followed by other people over the age of 75, then others who are younger and/or have underlying fitness problems.
The European Medicines Agency, the drug regulator that approves covid-19 vaccines for the European Union, said in a statement that its procedure to ensure the protection and efficacy of the vaccine is based on more evidence and more controls than the emergency authorisation used in the UK.
According to vaccine developers, MHRA asked for exactly the same amount of data as any other regulatory agency. He worked 24 hours a day, seven days a week to compare them, T-reci says.
There may still be serious side effects along the way, especially as mRN vaccines are a new generation and have never been implemented on a giant scale before.
Clinical trials of vaccines are neither giant nor long enough to rule out uncommon but serious side effects, which infrequently appear months or even years after vaccination. waiting for the scenes.
But those are small theoretical risks. As Fiona Watt of the UK Medical Research Council (MRC) said: “This is news. “
Subscribe to our loose Health Check newsletter for a summary of all the fitness and fitness news you want to know, every Saturday